Literature DB >> 9230217

Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.

M Auvinen1, A Laine, A Paasinen-Sohns, A Kangas, L Kangas, O Saksela, L C Andersson, E Hölttä.   

Abstract

Overexpression of human ornithine decarboxylase (ODC) under the control of strong promoters induces morphological transformation of immortalized NIH3T3 and Rat-1 fibroblasts [M. Auvinen et al., Nature (Lond.), 360: 355-358, 1992]. We demonstrate here that ODC-overproducing NIH3T3 cells are tumorigenic in nude mice, giving rise to rapidly growing, large fibrosarcomas at the site of inoculation. The tumors are capable of invading host fat and muscle tissues and are vascularized abundantly. To disclose the molecular mechanism(s) driving the tumorigenic, invasive, and angiogenic phenotype of the tumors, the ODC-overproducing cell lines and tumor tissues were analyzed for the expression of various potential regulators and mediators of cell proliferation, matrix degradation, and angiogenesis. The tumorigenicity of ODC transformants was associated with elevated polyamine levels and down-regulated growth factor receptors. The invasiveness of the ODC-induced tumors could not be attributed to overexpression of various known extracellular matrix-degrading proteases or matrix metalloproteinases. The induction of the tumor neovascularization proved not to be elicited by vascular endothelial growth factor or basic fibroblast growth factor. Instead, the ODC-overexpressing cells appeared to secrete a novel angiogenic factor(s) that was able to promote migration of bovine capillary endothelial cells in collagen gels and increase the proliferation of human endothelial cells in vitro. In parallel, ODC-transformed cells displayed down-regulation of thrombospondin-1 and -2, the negative regulators of angiogenesis. Thus, the induction of the angiogenic phenotype of the ODC transformants is likely due both to increased expression and secretion of the new angiogenesis-stimulating factor(s) and decreased production and release of the antiangiogenic thrombospondins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230217

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro.

Authors:  Chun-xiao Xu; Yun-fei Yan; Ya-pei Yang; Bin Liu; Jia-xuan Xin; Shi-min Chen; Wei Wang; Chun-ying Jiang; Zhao-xin Lu; Xian-xi Liu
Journal:  Mol Biol Rep       Date:  2010-06-09       Impact factor: 2.316

2.  The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity.

Authors:  I Ben-Porath; O Yanuka; N Benvenisty
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.

Authors:  Amita Shukla-Dave; Mireia Castillo-Martin; Ming Chen; Jose Lobo; Nataliya Gladoun; Ana Collazo-Lorduy; Faisal M Khan; Vladimir Ponomarev; Zhengzi Yi; Weijia Zhang; Pier P Pandolfi; Hedvig Hricak; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2016-10-19       Impact factor: 4.307

4.  HMG-I/Y, a new c-Myc target gene and potential oncogene.

Authors:  L J Wood; M Mukherjee; C E Dolde; Y Xu; J F Maher; T E Bunton; J B Williams; L M Resar
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.

Authors:  J Nilsson; B Grahn; O Heby
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

6.  Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis.

Authors:  Farrukh Afaq; Naghma Khan; Deeba N Syed; Hasan Mukhtar
Journal:  Photochem Photobiol       Date:  2010-10-14       Impact factor: 3.421

7.  Translocation of ornithine decarboxylase to the surface membrane during cell activation and transformation.

Authors:  M Heiskala; J Zhang; S Hayashi; E Hölttä; L C Andersson
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

8.  Effect of spermine synthase on the sensitivity of cells to anti-tumour agents.

Authors:  Yoshihiko Ikeguchi; Caroline A Mackintosh; Diane E McCloskey; Anthony E Pegg
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Regulation of all members of the antizyme family by antizyme inhibitor.

Authors:  Ursula Mangold; Ekkehard Leberer
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  Critical factors determining dimerization of human antizyme inhibitor.

Authors:  Kuo-Liang Su; Ya-Fan Liao; Hui-Chih Hung; Guang-Yaw Liu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.